The D2 dopamine receptor occupancy of risperidone and its relationship to extrapyramidal symptoms: A pet study
Authors:
- Shitij KapurSKShitij Kapur
- Gary RemingtonGRGary Remington
- Robert B ZipurskyRZRobert B Zipursky
- Alan A WilsonAWAlan A Wilson
- Sylvain HouleSHSylvain Houle
- 1 July 1995
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 57 (10) , PL103-PL107
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Positron Emission Tomography Studies on D2 and 5-HT2 Receptor Binding in Risperidone-Treated Schizophrenic PatientsJournal of Clinical Psychopharmacology, 1995
- Fluphenazine vs Placebo Supplementation for Prodromal Signs of Relapse in SchizophreniaArchives of General Psychiatry, 1994
- 5-HT2 and D2 dopamine receptor occupancy in the living human brainPsychopharmacology, 1993
- Positron Emission Tomographic Analysis of Central D1 and D2 Dopamine Receptor Occupancy in Patients Treated With Classical Neuroleptics and ClozapineArchives of General Psychiatry, 1992
- Positron emission tomography with (18F)methylspiperone demonstrates D2 dopamine receptor binding differences of clozapine and haloperidolJournal of Neural Transmission, 1991
- Optimal Dose of Neuroleptic in Acute SchizophreniaArchives of General Psychiatry, 1991
- 5-HT2 Antagonist Ritanserin in Neuroleptic-Induced ParkinsonismClinical Neuropharmacology, 1990
- A Rating Scale for Drug-Induced AkathisiaThe British Journal of Psychiatry, 1989
- D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neurolepticsPsychopharmacology, 1989
- Central D2-Dopamine Receptor Occupancy in Schizophrenic Patients Treated With Antipsychotic DrugsArchives of General Psychiatry, 1988